Nuveen Asset Management, LLC Exagen Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.18 - $7.74 $72,681 - $134,583	-17,388 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.97 - $14.08 $108,088 - $169,664	-12,050 Reduced 40.93%	17,388 $169,000
Q3 2021 Nov 12, 2021	SELL	$10.25 - $15.21 $15,805 - $23,453	-1,542 Reduced 4.98%	29,438 $425,000
Q2 2021 Aug 16, 2021	BUY	$12.4 - $17.92 $242,940 - $351,088	19,592 Added 172.04%	30,980 $465,000
Q2 2020 Aug 14, 2020	BUY	$11.0 - $16.7 $125,268 - $190,179	11,388 New	11,388 $141,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $81.6M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.